Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1731

Oct 24, 2019

Poor toilet hygiene behind E. coli superbug spread

Posted by in categories: biotech/medical, food

People not washing their hands after going to the toilet, rather than undercooked meat, is behind the spread of a key strain of E. coli.

Experts looked at thousands of blood, faecal and food samples.

They found human-to-human transmission was responsible — “faecal particles from one person reaching the mouth of another”.

Oct 23, 2019

Amazon buys healthcare start-up Health Navigator

Posted by in categories: biotech/medical, health

Marketing always starts with Demand (Reuters) — http://Amazon.com/ Inc said on Wednesday it bought healthcare start-up Health Navigator, its second purchase in the healthcare services industry.


(Reuters) — Amazon.com Inc said on Wednesday it bought healthcare start-up Health Navigator, its second purchase in the healthcare services industry.

The deal comes after the company acquired online pharmacy PillPack last year, pitting itself against drugstore chains, drug distributors and pharmacy benefit managers. (reut.rs/31DSU8k)

Continue reading “Amazon buys healthcare start-up Health Navigator” »

Oct 23, 2019

Heat camera at tourist attraction spots woman’s breast cancer

Posted by in categories: biotech/medical, electronics

A trip to a tourist attraction in Scotland turned out to be a life-changing moment for one woman after a thermal camera detected she had breast cancer.

Bal Gill, 41, was looking back over images from her trip to Camera Obscura and World of Illusions, in Edinburgh, when she noticed a heat patch over her breast.

Oct 23, 2019

Dr. Virginia Byers Kraus, MD, PhD — Cartilage Regeneration — Duke University — ideaXme — Ira Pastor

Posted by in categories: aging, bioengineering, biotech/medical, chemistry, DNA, genetics, health, life extension, posthumanism, science

Oct 23, 2019

Dr. Josh Mitteldorf — DataBETA Project — Population Scale Longevity Clinical Trials — ideaXme — Ira Pastor

Posted by in categories: aging, bioengineering, biotech/medical, genetics, health, life extension, neuroscience, posthumanism, science, transhumanism

Oct 22, 2019

New CRISPR editing tool could potentially fix 89% of genetic defects

Posted by in categories: biotech/medical, genetics

It’s a “precise new approach” to targeting and replacing mutated genes, scientists say.

Oct 22, 2019

Biological engineer Paul Blainey creates new tools to advance biomedical research

Posted by in category: biotech/medical

His technology platforms have benefited genomics, diagnostics, and drug screening.

Oct 22, 2019

Search-and-replace genome editing without double-strand breaks or donor DNA

Posted by in categories: biotech/medical, law

Okay, Science time.


  • Article
  • Published: 21 October 2019

This is an unedited manuscript that has been accepted for publication. Nature Research are providing this early version of the manuscript as a service to our customers. The manuscript will undergo copyediting, typesetting and a proof review before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers apply.

Oct 22, 2019

John Lewis at Ending Age-Related Diseases 2019

Posted by in categories: biotech/medical, life extension

We’re continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology.

John Lewis of Oisin Biotechnologies discussed senolytics, which are drugs that kill senescent cells. He explained the differences between healthy and senescent cells along with the senescence-associated secretory phenotype (SASP) responsible for systemic inflammation. He went into detail about senolytics and what his company looks for when creating them, including details about suicide genes and biomarkers of senescence. He also discussed issues with bringing these drugs to humans and suggested oncology as a possible method for bringing them to the clinic.

Oct 22, 2019

It Took Just Three Weeks for Superbug to Resist Last-Resort Drug, Doctors Say

Posted by in categories: biotech/medical, health

Just in time for Halloween, doctors in France say they witnessed a real-life horror tale involving an antibiotic-resistant superbug. In less than a month, their patient’s infection evolved resistance to the last-resort drug they had used to treat it. Thankfully, the doctors were still able to defeat the microscopic threat—and the case may have uncovered a peculiar weakness in the germ.

According to the report, published in the journal Antimicrobial Agents and Chemotherapy, a young child had been dealing with recurrent infections of the bacteria Pseudomonas aeruginosa for over two years. P. aeruginosa is an opportunistic infection that sickens tens of thousands of already weakened people in hospitals and other health-care settings in the U.S. a year. In these people, it can cause serious infections.